US Stock MarketDetailed Quotes

TMO Thermo Fisher Scientific

Watchlist
  • 510.990
  • -15.810-3.00%
Trading Mar 11 12:26 ET
192.78BMarket Cap30.91P/E (TTM)

About Thermo Fisher Scientific Company

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment provides a portfolio of reagents, instruments, and consumables used in biological and medical research, discovery, and production of new drugs and vaccines. The Analytical Instruments segment offers instruments and the supporting consumables, software, and services that are used for a range of applications. The Specialty Diagnostics segment includes a wide range of diagnostic test kits, reagents, culture media, instruments, and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The Laboratory Products and Biopharma Services segment is involved in virtually everything needed for the laboratory. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Company Profile

SymbolTMO
Company NameThermo Fisher Scientific
Listing DateJan 1, 1980
Issue Price27.25
Founded1960
CEOMr. Marc N. Casper
MarketNYSE
Employees125000
Fiscal Year Ends12-31
Address168 Third Avenue
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-781-622-1000

Company Executives

  • Name
  • Position
  • Salary
  • Marc N. Casper
  • Chairman of the Board, President and Chief Executive Officer
  • 18.98M
  • Michel Lagarde
  • Executive Vice President and Chief Operating Officer
  • 7.25M
  • Stephen Willian
  • Senior Vice President and Chief Financial Officer
  • 6.24M
  • Lisa P. Britt
  • Senior Vice President and Chief Human Resources Officer
  • 2.89M
  • Joseph R. Holmes
  • Vice President and Chief Accounting Officer
  • --
  • Michael A. Boxer
  • Senior Vice President and General Counsel
  • --
  • Gianluca Pettiti
  • Executive Vice President
  • 5.73M
  • Frederick M. Lowery
  • Executive Vice President
  • --
  • Michael D. Shafer
  • Executive Vice President
  • --
  • Professor Dr. Tyler E. Jacks, PhD
  • Director
  • 345.72K
  • Karen S. Lynch
  • Director
  • --
  • James C. Mullen
  • Independent Director
  • 325.72K
  • Dr. Debora L. Spar
  • Independent Director
  • 345.72K
  • Scott M. Sperling
  • Lead Independent Director
  • 403.12K
  • Nelson J. Chai
  • Independent Director
  • 365.72K
  • Dion J. Weisler
  • Independent Director
  • 353.19K
  • Jennifer M. Johnson
  • Independent Director
  • 59.07K
  • R. Alexandra Keith
  • Independent Director
  • 326.42K
  • Ruby R. Chandy
  • Independent Director
  • 340.72K
  • Dr. C. Martin Harris,M.D.
  • Independent Director
  • 325.72K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.